210 related articles for article (PubMed ID: 29017864)
1. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis.
Li L; Wu D; Yu Q; Li L; Wu P
Oncotarget; 2017 May; 8(19):32298-32308. PubMed ID: 28427178
[TBL] [Abstract][Full Text] [Related]
3. Clinical prognostic value of A FOXM1 related long non-coding RNA expression in gastric cancer.
Chong DQ; Shan JL; Yang CS; Wang R; Du ZM
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):417-421. PubMed ID: 29424899
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and prognostic significance of the RUNX3 expression in gastric cancer: a systematic review and meta-analysis.
Liu B; Han Y; Jiang L; Jiang D; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2018 May; 53():122-128. PubMed ID: 29578091
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological value of FoxM1 expression in colorectal cancer: A systematic review and meta-analysis.
Yao Y; Wang X; Jiang L; Shao X; Zhu X; He S
Medicine (Baltimore); 2018 Dec; 97(52):e13899. PubMed ID: 30593202
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
7. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
[TBL] [Abstract][Full Text] [Related]
8. Lack of relationship between PROX1 expression and clinicopathological parameters and prognosis in gastric cancer patients: a meta-analysis and TCGA analysis.
Jia Z; Wang Y; Gao J; Zu G
BMC Gastroenterol; 2022 Mar; 22(1):142. PubMed ID: 35346069
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
10. Tight correlation between FoxM1 and FoxP3+ Tregs in gastric cancer and their clinical significance.
Li X; Ma K; Song S; Shen F; Kuang T; Zhu Y; Liu Z
Clin Exp Med; 2018 Aug; 18(3):413-420. PubMed ID: 29804142
[TBL] [Abstract][Full Text] [Related]
11. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
[TBL] [Abstract][Full Text] [Related]
12. Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.
Hu L; Luo H; Wang W; Li H; He T
PLoS One; 2013; 8(10):e76927. PubMed ID: 24204707
[TBL] [Abstract][Full Text] [Related]
13. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis.
Yang Y; Gao P; Song Y; Sun J; Chen X; Zhao J; Ma B; Wang Z
Eur J Surg Oncol; 2016 Aug; 42(8):1176-82. PubMed ID: 27293109
[TBL] [Abstract][Full Text] [Related]
14. Expression and mechanism of exosome-mediated A FOXM1 related long noncoding RNA in gastric cancer.
Zhang Y; Chen L; Ye X; Wu Z; Zhang Z; Sun B; Fu H; Fu C; Liang X; Jiang H
J Nanobiotechnology; 2021 May; 19(1):133. PubMed ID: 33971889
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
16. [Expression of FoxM1 and BCRP in invasive breast carcinoma of no special type and its prognosis significance].
Liu Y; Liu YP; Liu JY; Yang HC; Wang ZD
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):30-33. PubMed ID: 28072973
[No Abstract] [Full Text] [Related]
17. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed immunofluorescence analysis of CAF-markers, EZH2 and FOXM1 in gastric tissue: associations with clinicopathological parameters and clinical outcomes.
Sun H; Wang X; Zhang X; Wang X; Tan C; Weng W; Zhang M; Ni S; Wang L; Huang D; Xu M; Sheng W
BMC Cancer; 2022 Nov; 22(1):1188. PubMed ID: 36401232
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
